Clinical trial
Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of…
NCT00333255 · Alcon Research, Industry · Completed
Key facts
| NCT number | NCT00333255 |
|---|---|
| Title | Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery |
| Official title | Preoperative and Postoperative Nevanac 0.1% Compared to Acular LS for the Treatment of Ocular Inflammation Associated With Cataract Surgery |
| Lead sponsor | Alcon Research, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cataract |
| Intervention type | Drug |
| Interventions | Nepafenac Ophthalmic Suspension, 0.1% |
| Enrollment | 267 |
| Start date | Sep 1, 2005 |
| Primary completion | Mar 1, 2006 |
| First posted | Jun 2, 2006 |
| Last update posted | Jul 8, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: